§ 2032. Powers; duties; limitations
(a) The Board shall adopt rules necessary for the performance of its duties, including:
(1) scope of the practice of pharmacy;
(2) qualifications for obtaining licensure;
(3) explanations of appeal and other rights given to licensees, applicants, and the public;
(4) rules regulating pharmacy technicians; and
(5) provisions for the inspection of any regulated entity or commercial location where
legend drugs are manufactured or kept.
(b) The Board of Pharmacy shall supervise the practice of pharmacy in this State, including
the following:
(1) the determination and issuance of standards for recognition and approval of schools
and colleges of pharmacy whose graduates shall be eligible for licensure in this State,
and the specification and enforcement of requirements for practical training;
(2) the enforcement of those provisions of this chapter relating to the conduct or competence
of pharmacists practicing in this State, and the suspension, revocation, or restriction
of licenses to engage in the practice of pharmacy; and
(3) an internship program that shall have the following elements:
(A) a curriculum governing the internship that requires an intern to spend at least 50
percent of the internship on compounding, dispensing, or inventorying prescription
drugs under the direct supervision of a licensed pharmacist, and maintaining required
records;
(B) the establishment of a referral function administered by the Office of Professional
Regulation whereby the Board collects information on available internships and disseminates
this information to prospective interns; and
(C) allowance of up to 1,240 hours of the program to be “concurrent time” or internship
time served under the supervision of, concurrent with, or part of an educational course
requirement leading to a pharmacy degree, as defined by Board rule, or by equivalent
service in any branch of the U.S. Armed Forces, as defined by Board rule.
(c) The Board of Pharmacy shall also have the following responsibilities in regard to
medications, drugs, legend devices, and other materials used in this State in the
diagnosis, mitigation, and treatment or prevention of injury, illness, and disease:
(1) the regulation of the sale, compounding, administration, and dispensing of medications,
drugs, legend devices, and other materials, including the right to seize any such
drugs, legend devices, and other materials found to be detrimental to the public health
and welfare by the Board pursuant to an appropriate hearing as required under the
Administrative Procedure Act;
(2) the specifications of minimum professional and technical equipment, environment, supplies,
and procedures for the compounding or dispensing of such medications, drugs, legend
devices, and other materials within the practice of pharmacy;
(3) the control of the purity and quality of such medications, drugs, legend devices,
and other materials within the practice of pharmacy; and
(4) the issuance of certificates of registration and licenses of drug outlets.
(d) The Board:
(1) shall make examinations available at least twice each year and pass upon the qualifications
of applicants for licensing; and
(2) may enact rules for continuing education requirements and approve continuing education
programs.
(e) With the approval of the Board, the Director of the Office of Professional Regulation
may employ or contract with persons as may be necessary to carry out the duties of
the Board.
(f) The Board or its authorized representatives shall also have power to investigate and
gather evidence concerning alleged violations of the provisions of this chapter or
of the rules and regulations of the Board. The Board may take testimony under oath
and may compel the attendance of witnesses and the production of tangible evidence
by serving a subpoena.
(g) The Board may by rule adopt standards for creating, licensing, and operating remote
pharmacies and automatic dispensing units in Vermont.
(h) It shall be lawful for a drug outlet licensed under this chapter to sell and distribute
nonprescription drugs. Drug outlets engaging in the sale and distribution of such
items shall not be deemed to be improperly engaged in the practice of pharmacy. A
rule or regulation shall not be adopted by the Board under this chapter that shall
require the sale of nonprescription drugs by a licensed pharmacist or under the supervision
of a licensed pharmacist or otherwise apply to or interfere with the sale and distribution
of such medicines. (Added 1977, No. 266 (Adj. Sess.), § 1; amended 1979, No. 158 (Adj. Sess.), § 4, eff. April 28, 1980; 1981, No. 244 (Adj. Sess.), § 4; 1983, No. 230 (Adj. Sess.), § 8; 1989, No. 250 (Adj. Sess.), § 4(d); 1997, No. 40, § 24; 2001, No. 127 (Adj. Sess.), § 2b, eff. June 13, 2002; 2003, No. 60, § 8; 2005, No. 148 (Adj. Sess.), § 17; 2007, No. 163 (Adj. Sess.), § 13; 2009, No. 4, § 104a, eff. April 29, 2009; 2009, No. 35, § 33; 2011, No. 66, § 6, eff. June 1, 2011; 2013, No. 27, § 23; 2019, No. 30, § 14.)